Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on Behalf of Stockholders and Encourages Investors to Contact the Firm
July 02, 2018 11:27 ET
|
Bragar Eagel & Squire
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) stockholders concerning the...
October 3rd Deadline in Lawsuit for Investors in shares of Keryx Biopharmaceuticals (NASDAQ:KERX) announced by Shareholders Foundation
September 28, 2016 11:25 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Sept. 28, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on October 3, 2016 in the lawsuit that was filed for certain investors in...
KERYX ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action
September 16, 2016 10:52 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Keryx Biopharmaceuticals, Inc. securities (NASDAQ:KERX) from February 25, 2016...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX
August 31, 2016 15:53 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Keryx Biopharmaceuticals,...